Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001352413-06-000003
Filing Date
2006-02-08
Accepted
2006-02-08 12:27:34
Documents
2
Period of Report
2006-02-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 10413
2 EDGAR SUPPORTING DOCUMENT poa-capone.txt EX-24 3238
  Complete submission text file 0001352413-06-000003.txt   15407
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 801-584-3600
Capone Mark Christopher (Reporting) CIK: 0001352413 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 06587927